Home › Core › ISCC-IDs › 28C921HixYdaF

View ISCC-ID

Core Data

28C921HixYdaF
ISCC-ID - digital asset identifier
CCFPwVLh4swaj-CTcYHiAiuyJHA-CDejGNufko12s-CRtCdAUyiz4aQ
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

parp1 expression activity and <i>ex vivo<i> sensitivity to the parp inhibitor talazoparib bmn 673 in chronic lymphocytic leukaem

Ledger Reference

coblo
Source Ledger/Blockchain
12408865
N-th ISCC Decleration on source ledger
7a5612287e80f40514d6d8b82683db11569831300f0cd76bf64506197ed50d10
Hash of block that includes the ISCC-DECLARATION
4248dab277fe25f3f8cabae91f0160f8aa4d94a455facbe89ce0577a4753cbc4
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "PARP1 expression, activity and <i>ex vivo</i> sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ashleigh Herriott", "@type": "Person"}, {"name": "Susan J. Tudhope", "@type": "Person"}, {"name": "Gesa Junge", "@type": "Person"}, {"name": "Natalie Rodrigues", "@type": "Person"}, {"name": "Miranda J. Patterson", "@type": "Person"}, {"name": "Laura Woodhouse", "@type": "Person"}, {"name": "John Lunec", "@type": "Person"}, {"name": "Jill E. Hunter", "@type": "Person"}, {"name": "Evan A. Mulligan", "@type": "Person"}, {"name": "Michael Cole", "@type": "Person"}, {"name": "Lisa M. Allinson", "@type": "Person"}, {"name": "Jonathan P. Wallis", "@type": "Person"}, {"name": "Scott Marshall", "@type": "Person"}, {"name": "Evelyn Wang", "@type": "Person"}, {"name": "Nicola J. Curtin", "@type": "Person"}, {"name": "Elaine Willmore", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/f269/fa2cb7875ce1aae55da1f22f5534bb67c9e3.pdf", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "https://eprint.ncl.ac.uk/fulltext.aspx?url=216676/617E2991-ADAC-473C-B5F9-E46A99A1EB50.pdf&pub_id=216676", "encodingFormat": "application/pdf"}], "publisher": {"name": "Impact Journals, LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.18632/oncotarget.6287", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCFPwVLh4swaj-CTcYHiAiuyJHA-CDejGNufko12s-CRtCdAUyiz4aQ", "propertyID": "ISCC"}], "datePublished": "2015-11-03"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close